Evaluation of the BDCA2-DTR Transgenic Mouse Model in Chronic and Acute Inflammation.

Plasmacytoid dendritic cells (pDCs) are a small subset of dendritic cells and the main producers of type I interferons. Besides their contribution to tolerance, they are known to be involved in autoimmune diseases and have recently been implicated in atherosclerosis. However, their precise involveme...

Full description

Bibliographic Details
Main Authors: Manuela Mandl, Maik Drechsler, Yvonne Jansen, Carlos Neideck, Heidi Noels, Alexander Faussner, Oliver Soehnlein, Christian Weber, Yvonne Döring
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4529211?pdf=render
id doaj-ef61bdcaf4b94cc8aed1aa881c036cc1
record_format Article
spelling doaj-ef61bdcaf4b94cc8aed1aa881c036cc12020-11-25T02:04:47ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01108e013417610.1371/journal.pone.0134176Evaluation of the BDCA2-DTR Transgenic Mouse Model in Chronic and Acute Inflammation.Manuela MandlMaik DrechslerYvonne JansenCarlos NeideckHeidi NoelsAlexander FaussnerOliver SoehnleinChristian WeberYvonne DöringPlasmacytoid dendritic cells (pDCs) are a small subset of dendritic cells and the main producers of type I interferons. Besides their contribution to tolerance, they are known to be involved in autoimmune diseases and have recently been implicated in atherosclerosis. However, their precise involvement, particularly in advanced lesion development, remains elusive. Hence, we investigated the role of pDCs in atherogenesis vs atheroprogression by specifically depleting this cell population using the BDCA2-DTR mouse model bred to Apolipoprotein E (Apoe-/-) deficient mice.Our results revealed that continuous diphtheria toxin-induced pDC depletion in Apoe-/- BDCA2-DTR mice receiving a high-fat diet (HFD) for 4 weeks did not alter lesion size or composition. Instead, these mice displayed increased B cell numbers and altered levels of inflammatory cytokines. Analysis of depletion efficiency showed that complete pDC depletion could only be sustained for one week and reoccurring pDCs sorted after 4 weeks did not express DTR anymore. Consequently, we analyzed lesion development in a model of partial carotid ligation, inducing established lesions after 5 weeks of HFD feeding, and only depleted pDCs during the last week of 5 weeks HFD feeding. Despite short-term, but efficient pDC depletion, we observed no differences in atherosclerotic lesion development, but changes in inflammatory cytokine titers. To assure the functionality of the BDCA2-DTR model in acute settings, we additionally examined the effect of pDC depletion in an indirect acute lung injury (iALI) model. This time, efficient pDC depletion resulted in a significantly reduced macrophage and neutrophil accumulation in the lung 12 hours after LPS challenge, underlining a pro-inflammatory role of pDCs in the innate immune response in iALI.Taken together, the BDCA2-DTR mouse model only allows efficient pDC depletion for one week, which subsequently restricts its usability to more acute but not chronic inflammatory disease models.http://europepmc.org/articles/PMC4529211?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Manuela Mandl
Maik Drechsler
Yvonne Jansen
Carlos Neideck
Heidi Noels
Alexander Faussner
Oliver Soehnlein
Christian Weber
Yvonne Döring
spellingShingle Manuela Mandl
Maik Drechsler
Yvonne Jansen
Carlos Neideck
Heidi Noels
Alexander Faussner
Oliver Soehnlein
Christian Weber
Yvonne Döring
Evaluation of the BDCA2-DTR Transgenic Mouse Model in Chronic and Acute Inflammation.
PLoS ONE
author_facet Manuela Mandl
Maik Drechsler
Yvonne Jansen
Carlos Neideck
Heidi Noels
Alexander Faussner
Oliver Soehnlein
Christian Weber
Yvonne Döring
author_sort Manuela Mandl
title Evaluation of the BDCA2-DTR Transgenic Mouse Model in Chronic and Acute Inflammation.
title_short Evaluation of the BDCA2-DTR Transgenic Mouse Model in Chronic and Acute Inflammation.
title_full Evaluation of the BDCA2-DTR Transgenic Mouse Model in Chronic and Acute Inflammation.
title_fullStr Evaluation of the BDCA2-DTR Transgenic Mouse Model in Chronic and Acute Inflammation.
title_full_unstemmed Evaluation of the BDCA2-DTR Transgenic Mouse Model in Chronic and Acute Inflammation.
title_sort evaluation of the bdca2-dtr transgenic mouse model in chronic and acute inflammation.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2015-01-01
description Plasmacytoid dendritic cells (pDCs) are a small subset of dendritic cells and the main producers of type I interferons. Besides their contribution to tolerance, they are known to be involved in autoimmune diseases and have recently been implicated in atherosclerosis. However, their precise involvement, particularly in advanced lesion development, remains elusive. Hence, we investigated the role of pDCs in atherogenesis vs atheroprogression by specifically depleting this cell population using the BDCA2-DTR mouse model bred to Apolipoprotein E (Apoe-/-) deficient mice.Our results revealed that continuous diphtheria toxin-induced pDC depletion in Apoe-/- BDCA2-DTR mice receiving a high-fat diet (HFD) for 4 weeks did not alter lesion size or composition. Instead, these mice displayed increased B cell numbers and altered levels of inflammatory cytokines. Analysis of depletion efficiency showed that complete pDC depletion could only be sustained for one week and reoccurring pDCs sorted after 4 weeks did not express DTR anymore. Consequently, we analyzed lesion development in a model of partial carotid ligation, inducing established lesions after 5 weeks of HFD feeding, and only depleted pDCs during the last week of 5 weeks HFD feeding. Despite short-term, but efficient pDC depletion, we observed no differences in atherosclerotic lesion development, but changes in inflammatory cytokine titers. To assure the functionality of the BDCA2-DTR model in acute settings, we additionally examined the effect of pDC depletion in an indirect acute lung injury (iALI) model. This time, efficient pDC depletion resulted in a significantly reduced macrophage and neutrophil accumulation in the lung 12 hours after LPS challenge, underlining a pro-inflammatory role of pDCs in the innate immune response in iALI.Taken together, the BDCA2-DTR mouse model only allows efficient pDC depletion for one week, which subsequently restricts its usability to more acute but not chronic inflammatory disease models.
url http://europepmc.org/articles/PMC4529211?pdf=render
work_keys_str_mv AT manuelamandl evaluationofthebdca2dtrtransgenicmousemodelinchronicandacuteinflammation
AT maikdrechsler evaluationofthebdca2dtrtransgenicmousemodelinchronicandacuteinflammation
AT yvonnejansen evaluationofthebdca2dtrtransgenicmousemodelinchronicandacuteinflammation
AT carlosneideck evaluationofthebdca2dtrtransgenicmousemodelinchronicandacuteinflammation
AT heidinoels evaluationofthebdca2dtrtransgenicmousemodelinchronicandacuteinflammation
AT alexanderfaussner evaluationofthebdca2dtrtransgenicmousemodelinchronicandacuteinflammation
AT oliversoehnlein evaluationofthebdca2dtrtransgenicmousemodelinchronicandacuteinflammation
AT christianweber evaluationofthebdca2dtrtransgenicmousemodelinchronicandacuteinflammation
AT yvonnedoring evaluationofthebdca2dtrtransgenicmousemodelinchronicandacuteinflammation
_version_ 1724941171682181120